Nutraceutical Clinical Laboratories International, Inc. Announces Two New Appointments

Burt Sookram, Vice President, Research & Development/Quality Assurance George Merrell, Plant Manager

ST. PETERSBURG, Fla., Feb. 25 -- Nutraceutical Clinical Laboratories International, Inc. (OTC: NCCL) today announced the appointments of Mr. Burt Sookram as Vice President, Research & Development/Quality Assurance and Mr. George Merrell, Plant Manager.

Burt Sookram, Special Projects Manager for United Beverage Group, brings years of experience to a host of leadership roles throughout a distinguished career in the food industry. Previously, he served as president of BAIT Corporation and Catalina Food Ingredients, Inc. Mr. Sookram was General Manager of FlavorTech, a division of Sara Lee. His extensive experience includes research and development, operational management, procurement, quality assurance, total quality management and sales. Mr. Sookram has developed several products for bakery, seafood, sport drinks, snack food seasoning, meats and the pizza industry sold in today's marketplace.

Mr. Sookram received his BS and MS in Chemistry from the University of Toronto, Canada.

George Merrell, Plant Manager for KIK International f.k.a., The Dial Corporation, has over twenty years of progressive, management experience.

Within the consumer products industry, Mr. Merrell has had direct responsibility for manufacturing, safety, quality, engineering, maintenance, and human resources.

Mr. Merrell received a Bachelor Arts in Social Science from Edinboro, University of Pennsylvania.

For complete biographical sketches on Mr. Sookram and Mr. Merrell, click on .

Paul Simmons, CEO, states, "We are extremely happy to welcome these two gentlemen to our staff. Their expertise and experience will enable us to ramp up our production to meet the demanding expectations of our customers."

NCLII is committed to researching, designing, producing, and marketing their line of natural preservatives and anti-aging supplements using the highest quality standards, procedures, protocols, and controls. Our products will be manufactured according to the Food and Drug Administration (FDA) criteria for Good Manufacturing Practices (GMP) and will be backed by thorough scientific testing and clinical trials.

Nutraceutical Clinical Laboratories International, Inc. trades on the OTC market under the symbol "NCCL" and can be found on the Internet at: , , , and . Additional company information may be found at Nutraceutical Clinical Laboratories International, Inc.'s website: .

Special note: Forward looking statements in this press release are made pursuant to the "safe harbor" provision of the Private Securities Litigation Act of 1995. Investors are cautioned that such forward looking statements involve risks and uncertainties, including without limitation, market acceptance of, demand for, the Company's products, manufacturing, development and distribution issues, product pricing, competition, technological changes and other risks not identified herein.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.